Potential treatment of Parkinson's disease using new-generation carbon nanotubes: a biomolecular in silico study

Nanomedicine (Lond). 2021 Feb;16(3):189-204. doi: 10.2217/nnm-2020-0372. Epub 2021 Jan 27.

Abstract

Background: One of the underlying mechanisms of Parkinson's disease is the aggregation of α-synuclein proteins, including amyloids and Lewy bodies in the brain. Aim: To study the inhibitory effect of doped carbon nanotubes (CNTs) on amyloid aggregation. Materials & methods: Molecular dynamics tools were utilized to simulate the influence of CNTs doped with phosphorus, nitrogen and bromine and nitrogen on the formation of α-synuclein amyloid. Results: The CNTs exhibited strong interactions with α-synuclein, with phosphorus-doped CNTs having the most substantial interactions. Conclusion: Doped-CNTs, especially phosphorus-doped carbon nanotube could effectively prevent α-synuclein amyloid formation, thus, it could be considered as a potential treatment for Parkinson's disease. However, further in vitro and clinical investigations are required.

Keywords: Parkinson’s disease; amyloid formation; molecular dynamics; nanotube; α-synuclein.

MeSH terms

  • Amyloid
  • Humans
  • Molecular Dynamics Simulation
  • Nanotubes, Carbon*
  • Parkinson Disease* / drug therapy
  • alpha-Synuclein

Substances

  • Amyloid
  • Nanotubes, Carbon
  • alpha-Synuclein